At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Nabilone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain
Azienda Ospedaliera Universitaria Policlinico "G. Martino"·observational·Posted Jul 7, 2017·Updated Jan 16, 2019
In Brief
An observational study evaluating Nabilone and THC/CBD for FBSS. Completed, enrolled 20 participants.
Detailed Summary
The aim of this study is to evaluate the efficacy of oral administration of nabilone or THC/CBD administration in combination with spinal cord stimulation (SCS) in FBSS patients refractory to other available therapeutic strategies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFBSS
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
Primary CompletionJan 2015
Study CompletionJan 2016
First PostedJul 2017
TodayJul 2026
First PostedJul 7, 2017
Enrollment StartSep 1, 2014
Primary CompletionJan 1, 2015
Study CompletionJan 31, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.0 years ago
Interventions
Nabilonedrug
THC/CBDdrug